Atopic Dermatitis – ACT17207
20220519101722

A Phase 2, randomized, double-blind, placebo controlled, multicenter proof-of-concept study evaluating efficacy and safety of rilzabrutinib in adult patients with moderate-to-severe atopic dermatitis who are inadequate responders or intolerant to topical corticosteroids. Register Today!

Plaque Psoriasis – (ME3183-3)
20220428152814

Phase 2a Study to Assess the Efficacy and Safety of ME3183 Administered Orally in Subjects with Moderate to Severe Plaque Psoriasis Register Today!</a

Atopic Dermatitis – P20-441
20220413114032

Real world utilization of upadacitinib in adult and adolescent patients living with moderate to severe atopic dermatitis (AD-VISE). Register Today!

Irritable Bowel Syndrome – 20.01.CLI
20210913112541

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Bifidobacterium longum (BL) NCC3001 on Intestinal and Psychological Symptoms in Subjects with Irritable Bowel Syndrome (IBS) Register Today!

Testosterone and Economic Decision Making (TED Study)
20210426105104

This study will examine the role of testosterone in modulating human economic decision making. To determine whether testosterone plays a causal role in such processes, the study involves the administration of a single dose of testosterone (or placebo) and assessment of decision-making. The proposed experiment builds upon a growing body of evidence demonstrating that testosterone…

Osteoarthritis of the Knee (BP-2020-G001-P2)
20210126110900

This trial is a Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle- Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of G001 in Patients with Osteoarthritis (OA) of the Knee. The objectives of this study are to explore the efficacy, safety, and local tolerability of G001 compared to vehicle in patients with symptomatic osteoarthritis…